(Q34204618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Multifocal motor neuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author

Eduardo Nobile-Orazio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Nobile-Orazio E

series ordinal

1

1 reference

31 July 2017

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

4-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Acute conduction block in vitro following exposure to antiganglioside sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Long term follow up of multifocal motor neuropathy with conduction block under treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy mimicking motor neuron disease: nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy with conduction block: a study of 24 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy: a source of error in the serial evaluation of conduction block.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Criteria for early detection of conduction block in multifocal motor neuropathy (MMN): a study based on control populations and follow-up of MMN patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Deterioration of multifocal motor neuropathy after plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Rapidly progressive multifocal motor neuropathy with phrenic nerve paralysis: effect of nocturnal assisted ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Intravenous immunoglobulin treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy: response to human immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy: electrodiagnostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Plasmapheresis in multifocal motor neuropathy: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Conduction block in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Sensory nerve pathology in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Chronic multifocal demyelinating neuropathy simulating motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Use of human intravenous immunoglobulin in lower motor neuron syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Immunosuppressive treatment in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Chronic acquired demyelinating motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

To test or not to test? That is the question

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy: clinical and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pathological findings at the site of conduction block in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Activity-dependent conduction block in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Electrophysiologic findings in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Intravenous immunoglobulin for multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The clinical and diagnostic role of anti-GM1 antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Chronic motor neuropathies: diagnosis, therapy, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

A syndrome of asymmetric limb weakness with motor conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Localization of GM1 and GD1b antigens in the human peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Persistent and transient "conduction block" in motor neuron diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

AAEM news and comments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Central motor conduction time in patients with multifocal motor conduction block.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pattern of nervous tissue immunostaining by human anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy without overt conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

AAEM case report #30: multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Are multifocal motor neuropathy and Lewis-Sumner syndrome distinct nosologic entities?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy presenting as ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

A computer simulation of conduction block: effects produced by actual block versus interphase cancellation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy human sera block distal motor nerve conduction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Motor Neuropathy with Proximal Multifocal Persistent Conduction Block, Fasciculations and Myokymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The spectrum of neurologic disease associated with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Experimental conduction block induced by serum from a patient with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Intravenous immunoglobulin treatment of neurological autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The sensitivity and specificity of anti-GM1 antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Natural history of 46 patients with multifocal motor neuropathy with conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Human Monoclonal IgM Anti-Gal(β1-3)GaINAc Autoantibodies Bind to the Surface of Bovine Spinal Motoneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Abnormal sensory nerve conduction in multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Motor neuropathy with multifocal conduction blocks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Treatment of multifocal motor neuropathy with interferon-beta1A

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

IVIg treatment improves multifocal motor neuropathy: easy to start but difficult to stop

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Multifocal motor neuropathy with conduction block and Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

The immunopathogenesis of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Cloning of human anti-GM1 antibodies from motor neuropathy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900266-1

7 January 2021

10.1016/S0165-5728(01)00266-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282149%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference